Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

No abstract is available for this paper.

• Publication year

  2000

• Venue

  The Lancet

• Publication date

  2000-07-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(00)02527-7PMID 10972368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of diabetes and type of hypertension on response to antihypertensive treatment.

  2000cited by this paper
• Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

  2000cited by this paper
• Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus

  2000cited by this paper
• Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations.

  2000cited by this paper
• What does STOP-2 tell us about management of hypertension?

  2000cited by this paper
• What does STOP-2 tell us about management of hypertension? INSIGHT Steering Committee.

  2000cited by this paper
• Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

  2000cited by this paper
• Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.

  2000cited by this paper
• Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

  1999cited by this paper
• British Hypertension Society guidelines for hypertension management 1999: summary

  1999cited by this paper
• CAPPP trial. Captopril Prevention Project.

  1999cited by this paper
• 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

  1999cited by this paper
• 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization.

  1999cited by this paper
• Optimisation of antihypertensive treatment by crossover rotation of four major classes.

  1999cited by this paper
• An overview of 37 randomised trials of blood pressure lowering agents among 270,000 individuals. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.

  1999cited by this paper
• Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

  1999cited by this paper
• Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension

  1998cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA Project. World Health Organization. Monitoring trends and determinants in cardiovascular diseases.

  1998cited by this paper
• Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

  1998cited by this paper
• Minimisation: the platinum standard for trials?

  1998cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

  1997cited by this paper
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

  1997cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension *

  1997cited by this paper
• Calcium-channel blockade and incidence of cancer in aged populations.

  1996cited by this paper
• Shanghai trial of nifedipine in the elderly (STONE).

  1996cited by this paper
• INSIGHT: international nifedipine GITS study intervention as a goal in hypertension treatment.

  1996cited by this paper
• Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old.

  1996cited by this paper
• Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.

  1995cited by this paper
• Long‐Term Survival and Use of Antihypertensive Medications in Older Persons

  1995cited by this paper
• Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease.

  1994cited by this paper
• Diuretic therapy for hypertension and the risk of primary cardiac arrest.

  1994cited by this paper
• Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

  1990cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper

• Optimizing Nephron Performance: The Old, the New, and the New–Old Diuretic Therapies

  2025cites this paper
• Population Pharmacokinetics of Nifedipine in High‐Altitude and Plain Patients with Hypertension

  2025cites this paper
• Comparative efficacy of different antihypertensive drug classes for stroke prevention: A network meta-analysis of randomized controlled trials

  2025cites this paper
• Evaluation of Aldosterone Suppression by Cinnarizine, a Putative Cav1.3 Inhibitor

  2025cites this paper
• Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients with Heart Failure with or without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized Trial

  2024cites this paper
• Long-acting nifedipine in the management of essential hypertension: a review for cardiologists.

  2024cites this paper
• Is fluid retention a cardiovascular risk factor?

  2024cites this paper
• CYSTATIN C AS A MARKER OF EARLY KIDNEY DAMAGE UNDER ARTERIAL HYPERTENSION (LITERATURE REVIEW)

  2024cites this paper
• Diuretics use in the management of hypertension.

  2024cites this paper
• Natural L-type calcium channels antagonists from Chinese medicine

  2024cites this paper
• Blood Pressure Control in the DIAbetes and LifEstyle Cohort Twente (DIALECT): The Role of Patient Adherence and Physician’s Follow-Up Action

  2023cites this paper
• A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality.

  2023cites this paper
• First-line diuretics versus other classes of antihypertensive drugs for hypertension.

  2023cites this paper
• Calcium channel blockers for hypertension: old, but still useful

  2023cites this paper
• of the Hong Kong College of Cardiology

  2023cites this paper
• Thiazide diuretics alone or combined with potassium-sparing diuretics to treat hypertension: a systematic review and network meta-analysis of randomized controlled trials

  2023cites this paper
• Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials

  2022cites this paper
• Catalytic SrMoO4 nanoparticles and conducting polymer composite sensor for monitoring of K+-induced dopamine release from neuronal cells.

  2022cites this paper
• Association of diuretic use with increased risk for long-term post-transplantation diabetes mellitus in kidney transplant recipients

  2022influential citation
• Reno protective role of amlodipine in patients with hypertensive chronic kidney disease

  2022cites this paper
• 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

  2022cites this paper
• и нефропротективная эффективность фозиноприла у полиморбидных пациентов

  2022cites this paper
• Factors Associated with Antiretroviral Therapy Toxicity Out-Comes in Patients with and without Hypertension

  2022cites this paper
• Cardiovascular Disease Risk Factors in Hypertensive Patients: A Case Study of Jimma University Medical Center

  2022cites this paper
• Progression of chronic kidney disease in non- dialysis patients: a retrospective cohort

  2022cites this paper
• Nicardia® XL (Nifedipine Extended Release): Technologically Advanced GITS Formulation Ensures Robust Efficacy and Assured Safety

  2022cites this paper
• Effect of Calcium Channel Blockers versus Diuretics for Hypertension

  2022cites this paper
• SGLT2 Inhibitors and Peripheral Vascular Events: A Review of the Literature.

  2022cites this paper
• Clinical predictors of hyponatremia in patients with heart failure according to severity of chronic kidney disease

  2022cites this paper
• Calcium channel blockers versus other classes of drugs for hypertension.

  2022cites this paper
• Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker

  2021cites this paper
• The attention on gender in studies on the treatment of hypertension : was it enough ?

  2021cites this paper
• Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis

  2021cites this paper
• SGLT2 inhibitors and lower limb complications: the diuretic-induced hypovolemia hypothesis

  2021cites this paper
• Possibilities of using fosinopril in treatment of patients with chronic kidney disease in combination with cardiovascular diseases and diabetes mellitus

  2021cites this paper
• Adherence to antihypertensive medications for secondary prevention of cardiovascular disease events: a dose-response meta-analysis.

  2021cites this paper
• Calcium channel blockers versus other classes of drugs for hypertension.

  2021cites this paper
• Role of Blood Pressure Management in Stroke Prevention: A Systematic Review and Network Meta-Analysis of 93 Randomized Controlled Trials

  2021cites this paper
• Effectiveness and Tolerability of Nifedipine GITS in Patients with Chronic Kidney Disease and Uncontrolled Hypertension: A Prospective, Multicenter, Observational Study (ADRENAL)

  2021cites this paper
• Guide de Pratique Clinique. Prise en charge de l’hypertension artérielle chez l’adulte en Tunisie

  2021influential citation
• Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

  2021cites this paper
• Preliminary Experiment on the Effect of 18% Substitute Salt on Home Blood Pressure Variability in Hypertensives

  2021cites this paper
• Effects of Blood Pressure Lowering Agents on Cardiovascular Outcomes in Weight Excess Patients: A Systematic Review and Meta-analysis

  2020cites this paper
• Primary Hypertension

  2020cites this paper
• Hypertension

  2020cites this paper
• The Correlation Between Lipid Profile and Renal Function Tests in Patients with Cardiovascular Disease

  2020cites this paper
• Comparison of Cardiovascular Events Among Users of Different Classes of Antihypertension Medications

  2020cites this paper
• First-line combination therapy versus first-line monotherapy for primary hypertension.

  2020cites this paper
• Approach to Chronic Kidney Disease in the Diabetic Patient

  2020cites this paper
• Die Behandlung der arteriellen Hypertonie mit Angiotensin-Rezeptorblockern

  2020cites this paper
• Carbon nanomaterials integrated molecularly imprinted polymers for biological sample analysis: A critical review

  2020cites this paper
• Comparison of short-acting versus extended-release nifedipine: Effects on hemodynamics and sympathetic activity in patients with stable coronary artery disease

  2020cites this paper
• Reduced Lymphatic Function Predisposes to Calcium Channel Blocker Edema: A Randomized Placebo-Controlled Clinical Trial

  2020cites this paper
• Experimental determination and computational analysis of solid–liquid phase equilibrium of nifedipine in twelve pure solvents

  2020cites this paper
• Impact of topical nifedipine on wound healing in animal model (pig)

  2020cites this paper
• Efficacy and safety outcomes of one generic nifedipine versus ADALAT long‐acting nifedipine for hypertension management

  2020cites this paper
• Vascular Kv7 channels control intracellular Ca2+ dynamics in smooth muscle

  2020cites this paper
• Clinical efficacy of various anti-hypertensive regimens in hypertensive women of Punjab; a longitudinal cohort study

  2020cites this paper
• Hydrochlorothiazide therapy: impact on early recurrence of atrial fibrillation after catheter ablation?

  2020cites this paper
• Independent effects of 15 commonly prescribed drugs on all-cause mortality among US elderly patients with type 2 diabetes mellitus

  2020cites this paper
• Development of an electroanalytical methodology using differential pulse voltammetry for amiloride determination

  2020cites this paper
• Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk

  2020cites this paper
• Antihypertensive Therapie bei Typ 2-Diabetes: State of the Art 2002

  2020influential citation
• 2018 Chinese Guidelines for Prevention and Treatment of Hypertension—A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension

  2019cites this paper
• Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial

  2019cites this paper
• Twenty-four-hour ambulatory blood pressure changes in older patients with essential hypertension receiving monotherapy or dual combination antihypertensive drug therapy

  2019cites this paper
• Влияние магния оротата на морфофункциональное состояние артерий у курящих и некурящих женщин в постменопаузе

  2019cites this paper
• Hypertension control among euvolemic hypertensive hemodialysis patients in Malaysia: a prospective follow-up study

  2019cites this paper
• Calcium Channel Blockers Co-prescribed with Loop Diuretics: A Potential Marker of Poor Prescribing?

  2019cites this paper
• Pharmacological and Nutritional Modulation of Vascular Calcification

  2019cites this paper
• Die Behandlung der arteriellen Hypertonie mit Angiotensin-Rezeptorblockern

  2019cites this paper
• Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic use

  2019cites this paper
• The relationship between glucose variability and insulin sensitivity and oxidative stress in subjects with prediabetes.

  2019cites this paper
• Assessing hypertension therapies: randomization or confounding by indication?

  2019cites this paper
• Blood Pressure-Lowering Treatment and the Prevention of Heart Failure: Differences and Similarities of Antihypertensive Drug Classes

  2019cites this paper
• Differential effects on out-of-hospital cardiac arrest of dihydropyridines: real-world data from population-based cohorts across two European countries

  2019cites this paper
• Impact of Drugs on Diabetes Risk and Glycemic Control

  2019cites this paper
• Léčba hypertenze u pacientů s diabetes mellitus 2 . typu

  2019influential citation
• Conceptual Evolution of Cell Signaling

  2019cites this paper
• Drug in Adhesive Transdermal Formulation of Valsartan and Nifedipine: Pharmacokinetics and Pharmacodynamics in Rats

  2019cites this paper
• Schernthaner ANTIHYPERTENSIVE THERAPIE BEI TYP 2-DIABETES : STATE OF THE ART 2002

  2019influential citation
• Comparative risk of new‐onset diabetes mellitus for antihypertensive drugs in elderly: A Bayesian network meta‐analysis

  2019cites this paper
• 2019 Chinese guideline for the management of hypertension in the elderly

  2019cites this paper
• Methods of Blood Pressure Assessment Used in Milestone Hypertension Trials

  2018cites this paper
• Increase in perfused boundary region of endothelial glycocalyx is associated with higher prevalence of ischemic heart disease and lesions of microcirculation and vascular wall

  2018cites this paper
• Drug treatment of hypertension in older patients with diabetes mellitus

  2018cites this paper
• Diuretic therapy in hypertension: is it still the first choice?

  2018cites this paper
• Calcium Channel Blockers for the Clinical Management of Hypertension

  2018cites this paper
• Pro und Kontra: Kritische Einwände gegen den generellen Einsatz von Diuretika in der First-Line-Therapie der Hypertonie

  2018cites this paper
• Left Ventricular Hypertrophy Predicts Cardiovascular Events in Hypertensive Patients With Coronary Artery Calcifications

  2018cites this paper
• Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension

  2018cites this paper
• Prevention and Treatment

  2018cites this paper
• Novel therapies for diabetic kidney disease.

  2018cites this paper
• Evaluation of Blood Pressure Control Medicines Using Health and Medical Checkup Data in Japan: Alternative Methods for Randomized Controlled Trials

  2018cites this paper
• Outcomes of Different Antihypertensive Regimens

  2018cites this paper
• Schernthaner ANTIHYPERTENSIVE THERAPIE BEI TYP 2-DIABETES : STATE OF THE ART 2002

  2018influential citation
• 31 – Hypertension in Ischemic Heart Disease

  2018cites this paper
• 22 – Diuretics in Hypertension

  2018cites this paper
• Différences sur le plan de l’efficacité et des effets indésirables métaboliques entre les diurétiques thiazidiques

  2018cites this paper
• Differentialtherapie mit Kalziumantagonisten

  2018cites this paper